Zoledronate and malignant neoplasm progression Patient Reports February 12, 2012

Zoledronate Side Effects Report #4714915-8
Zoledronate side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2005. Female patient, 45 years of age, was diagnosed with multiple myeloma  and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: aseptic necrosis bone, bone disorder, malignant neoplasm progression, multiple myeloma , tooth extraction. Zoledronate dosage: 4 MG MONTHLY. During the same period patient was treated with DECADRON, AREDIA. Patient died on 02/04/2005.

Zoledronate Side Effects Report #4756606-3
Zoledronate side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2005. Female patient, 45 years of age, was diagnosed with multiple myeloma  and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: aseptic necrosis bone, bone disorder, malignant neoplasm progression, tooth extraction. Zoledronate dosage: 4 MG MONTHLY. During the same period patient was treated with DECADRON, AREDIA. Patient died on 01/31/2005.

Zoledronate Side Effects Report #4668252-0
Zoledronate side effect was reported by a Physician from on Apr 01, 2005. Female patient, 68 years of age, weighting 180.8 lb, was diagnosed with metastases to bone and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: aseptic necrosis bone, jaw disorder, malignant neoplasm progression, osteonecrosis , tooth abscess. Zoledronate dosage: 4 MG EVERY 4 WEEKS. Patient recovered.

Zoledronate Side Effects Report #4817325-8
Zoledronate side effect was reported by a Health Professional from FRANCE on Oct 24, 2005. Female patient, 57 years of age, was diagnosed with metastases to bone and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: bone disorder, gingival operation, hepatic failure, impaired healing, malignant neoplasm progression, osteomyelitis, osteonecrosis , sequestrectomy, tooth loss. Zoledronate dosage: unknown. Patient died on 11/01/2004.


Zoledronate Side Effects Report #4668677-3
Zoledronate side effect was reported by a Consumer or non-health professional from on Apr 14, 2005. Female patient, 77 years of age, weighting 130.1 lb, was diagnosed with breast cancer metastatic, breast cancer female and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: bone debridement, breath sounds decreased, fatigue, malignant neoplasm progression, oedema peripheral, oral pain, osteomyelitis. Zoledronate dosage: 4 MG EVERY 4 WEEKS. During the same period patient was treated with FASLODEX, XELODA, TAXOTERE, DEXAMETHASONE, METOPROLOL. Patient recovered.

Zoledronate Side Effects Report #4692823-9
Zoledronate side effect was reported by a Health Professional from on Apr 14, 2005. Female patient, 77 years of age, weighting 130.1 lb, was diagnosed with breast cancer metastatic, breast cancer female and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: bone debridement, breath sounds decreased, fatigue, malignant neoplasm progression, oral pain, osteomyelitis, osteonecrosis , primary sequestrum, sequestrectomy. Zoledronate dosage: 4 MG EVERY 4 WEEKS. During the same period patient was treated with FASLODEX, XELODA, TAXOTERE, DEXAMETHASONE, METOPROLOL. Patient recovered.